Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 613 Records) |
| Query Trace: Lung Neoplasms and TP53[original query] |
|---|
| Clinical characteristics of KRAS mutation subtypes in non-small cell lung cancer population in Xinjiang, China, and their impact on the prognosis of immunotherapy. Journal of cancer research and clinical oncology 2024 9 150 (9): 413. Guomin Gu, Chunling Liu, Xiaodan Zhu, Yan Yang, Shuming Song, Yan Zhao, Gang S |
| Molecular profiling METex14+ non-small cell lung cancer (NSCLC): Impact of histology. Lung cancer (Amsterdam, Netherlands) 2024 9 196 107935. Jennifer A Marks, Nishant Gandhi, Balazs Halmos, Melina E Marmarelis, So Yeon Kim, Lyudmila Bazhenova, Suresh S Ramalingam, Joanne Xiu, Phillip Walker, Matthew J Oberley, Patrick C Ma, Stephen V L |
| Next-generation sequencing as a valuable tool for mutational spectrum in advanced-stage NSCLC patients. Medicine and pharmacy reports 2024 9 97 (3): 298-307. Ioana Iurca, Ecaterina Isakescu, Laura Ancuta Pop, Liviuta Budisan, Radu Pirlog, Antonia Harangus, Tudor Eliade Ciuleanu, Cornelia Braicu, Ioana Berindan-Neag |
| Clinical Utility of Circulating Tumor DNA for Detecting Lung Cancer Mutations by Targeted Next-Generation Sequencing With Insufficient Tumor Samples. Journal of clinical laboratory analysis 2024 9 e25099. Yi Sun, Xu Zhang, Xinhua Yang, Jiangjun |
| Immunohistochemistry of p53 surrogates TP53 mutation as an accurate predictor for early-relapse of surgically resected stage I-III lung adenocarcinoma. JTCVS open 2024 9 20 183-193. Yasuyuki Kurihara, Takayuki Honda, Akira Takemoto, Katsutoshi Seto, Satoshi Endo, Kousuke Tanimoto, Susumu Kirimura, Masashi Kobayashi, Shunichi Baba, Yasuhiro Nakashima, Ryo Wakejima, Rie Sakakibara, Hironori Ishibashi, Johji Inazawa, Toshihiro Tanaka, Yasunari Miyazaki, Kenichi Oku |
| The NF1 gene mutations and co-mutations in lung adenocarcinomas with brain metastasis. Indian journal of pathology & microbiology 2024 9 . Nesibe Kahraman-Cetin, Dilara Akin, Seda Orenay-Boyacioglu, Olcay Boyacioglu, Ibrahim Halil Erdogdu, Esin Oktay, Ibrahim Meteog |
| The Study of PIK3CA Hotspot Mutations and Co-Occurring with EGFR, KRAS, and TP53 Mutations in Non-Small Cell Lung Cancer. OncoTargets and therapy 2024 9 17 755-763. YuXuan Zhang, Yuhong Shen, Jiayuan Wu, Jun Zhang, Chenxi Cao, Juanfen Mo, Yi B |
| Evaluation of the novel International Association for the Study of Lung Cancer grading system in adenocarcinoma with spread through air space. Translational lung cancer research 2024 9 13 (8): 1862-1876. Kuan Xu, Yilv Lv, Tangbing Chen, Yuchen Han, Hanqing Huang, Hong Yu, Bo |
| Loss of STK11 Suppresses Lipid Metabolism and Attenuates KRAS-Induced Immunogenicity in Patients with Non-Small Cell Lung Cancer. Cancer research communications 2024 8 . Daniel R Principe, Mary M Pasquinelli, Ryan H Nguyen, Hidayatullah G Munshi, Alicia Hulbert, Alexandre F Aissa, Frank Weinbe |
| Ancestry-, Sex-, and Age-Based Differences of Gene Alterations in NSCLC: From the Real-World Data of Cancer Genomic Profiling Tests. Journal of the National Comprehensive Cancer Network : JNCCN 2024 8 1-10. Keita Miura, Takehito Shukuya, Ray Greenstein, Ben Kaplan, Heather Wakelee, Kana Kurokawa, Kazuyuki Furuta, Shunsuke Kato, Junghee Suh, Smruthy Sivakumar, Ethan S Sokol, David P Carbone, Kazuhisa Takahas |
| Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2024 8 195 107917. Akihiro Tamiya, Mitsuo Osuga, Daijiro Harada, Shun-Ichi Isa, Yoshihiko Taniguchi, Keiichi Nakamura, Yasuyuki Mizumori, Tsutomu Shinohara, Hidetoshi Yanai, Katsumi Nakatomi, Masahide Oki, Masahide Mori, Tomohito Kuwako, Koji Yamazaki, Atsuhisa Tamura, Masahiko Ando, Yasuhiro K |
| Landscape of Concomitant Driver Alterations in Classical EGFR-Mutated Non-Small Cell Lung Cancer. JCO precision oncology 2024 8 8 e2300520. Huaying Wang, Lie Lin, Chuqiao Liang, Jiaohui Pang, Jiani C Yin, Junli Zhang, Yang Shao, Chengming Sun, Renhua G |
| Comparative genomic and immunopathologic analysis of lung adenocarcinomas with and without cytology-proven malignant pleural effusions. Cancer cytopathology 2024 8 . Cristiana M Pineda, Adnan Majid, Daniel B Costa, Paul A VanderLa |
| TP53 co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS, STK11 and KEAP1 mutations. Frontiers in oncology 2024 8 14 1357583. Armin Frille, Myriam Boeschen, Hubert Wirtz, Mathias Stiller, Hendrik Bläker, Maximilian von Laffe |
| RBM10 Mutation as a Potential Negative Prognostic/Predictive Biomarker to Therapy in Non-Small-Cell Lung Cancer. Clinical lung cancer 2024 8 . Amanda Reyes, Michelle Afkhami, Erminia Massarelli, Jeremy Fricke, Isa Mambetsariev, Xiaochen Li, Giovanny Velasquez, Ravi Salg |
| Impact of TP53 mutations on brain metastasis control in non-small cell lung cancer patients undergoing stereotactic radiosurgery. Journal of radiosurgery and SBRT 2024 8 9 (2): 91-99. Jim X Leng, Chang Su, David J Carpenter, Warren Floyd, Eugene Vaios, Rachel Shenker, Peter G Hendrickson, Will Giles, Trey Mullikin, Scott R Floyd, John P Kirkpatrick, Michelle Green, Zachary J Reitm |
| Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung). Journal of translational medicine 2024 7 22 (1): 714. Fabrizio Citarella, Kazuki Takada, Priscilla Cascetta, Pierfilippo Crucitti, Roberta Petti, Bruno Vincenzi, Giuseppe Tonini, Francesco M Venanzi, Alessandra Bulotta, Sara Oresti, Carlo Greco, Sara Ramella, Lucio Crinò, Angelo Delmonte, Roberto Ferrara, Massimo Di Maio, Fiorella Gurrieri, Alessio Cortelli |
| Highly consistency of PIK3CA mutation spectrum between circulating tumor DNA and paired tissue in lung cancer patients. Heliyon 2024 7 10 (13): e34013. Yan Liu, Hui Li, Xiang Li, Tingting Zhang, Yang Zhang, Jing Zhu, Heran Cui, Rixin Li, Ying Che |
| WFDC2 is a potential prognostic and immunotherapy biomarker in lung adenocarcinoma. The Journal of international medical research 2024 7 52 (7): 3000605241258893. Bo Min, Yan Wa |
| The Advantage of Targeted Next-Generation Sequencing over qPCR in Testing for Druggable EGFR Variants in Non-Small-Cell Lung Cancer. International journal of molecular sciences 2024 7 25 (14): . Adam Szpechcinski, Joanna Moes-Sosnowska, Paulina Skronska, Urszula Lechowicz, Magdalena Pelc, Malgorzata Szolkowska, Piotr Rudzinski, Emil Wojda, Krystyna Maszkowska-Kopij, Renata Langfort, Tadeusz Orlowski, Pawel Sliwinski, Mateusz Polaczek, Joanna Chorostowska-Wynim |
| Impact of EML4-ALK variants and co-occurring TP53 mutations on duration of first-line ALK tyrosine kinase inhibitor treatment and overall survival in ALK fusion-positive NSCLC: Real-world outcomes from the GuardantINFORM database. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 7 . Kaushal Parikh, Anastasios Dimou, Konstantinos Leventakos, Aaron S Mansfield, Mohamed Shanshal, Yin Wan, Huamao M Lin, Sylvie Vincent, Jennifer Elliott, Ioana R Bon |
| Sex- and Age-Associated Differences in Genomic Alterations among Patients with Advanced Non-Small Cell Lung Cancer (NSCLC). Cancers 2024 7 16 (13): . ErinMarie O Kimbrough, Julian A Marin-Acevedo, Leylah M Drusbosky, Ariana Mooradian, Yujie Zhao, Rami Manochakian, Yanyan L |
| Predictive [F]-FDG PET/CT-Based Radiogenomics Modelling of Driver Gene Mutations in Non-small Cell Lung Cancer. Academic radiology 2024 7 . Ricarda Hinzpeter, Roshini Kulanthaivelu, Andres Kohan, Vanessa Murad, Seyed Ali Mirshahvalad, Lisa Avery, Claudia Ortega, Ur Metser, Andrew Hope, Jonathan Yeung, Micheal McInnis, Patrick Veit-Haiba |
| A pilot study of nintedanib in molecularly selected patients with advanced non-small cell lung cancer. Journal of thoracic disease 2024 7 16 (6): 3782-3793. Christine Auberle, Feng Gao, Mark Sloan, Daniel Morgensztern, Linda Winkler, Jeffrey P Ward, Siddhartha Devarakonda, Timothy P Rearden, Ramaswamy Govindan, Saiama N Waq |
| Prevalence of pathogenic or likely pathogenic germline variants in cancer predisposition genes among selected patients with lung adenocarcinoma: The GERMLUNG study. Lung cancer (Amsterdam, Netherlands) 2024 6 194 107864. Oscar Arrieta, Enrique Caballé-Pérez, Norma Hernández-Pedro, Eunice Romero-Nuñez, José Lucio-Lozada, Cesar Castillo-Ruiz, Karla Acevedo-Castillo, Rosa María Álvarez-Gómez, Carolina Molina-Garay, Marco Jiménez-Olivares, Karol Carrillo-Sánchez, Elvia Cristina Mendoza-Caamal, Andrés F Cardona, Jordi Remon, Carmen Alaez-Vers |
| Molecular profile of driver genes in lung adenocarcinomas of Brazilian patients who have never smoked: implications for targeted therapies. The oncologist 2024 6 . Rodrigo de Oliveira Cavagna, Flávia Escremim de Paula, Gustavo Noriz Berardinelli, Murilo Bonatelli, Iara Santana, Eduardo Caetano Albino da Silva, Gustavo Ramos Teixeira, Beatriz Garbe Zaniolo, Josiane Mourão Dias, Flávio Augusto Ferreira da Silva, Carlos Eduardo Baston Silva, Marcela Gondim Borges Guimarães, Camila Pinto Barone, Alexandre Arthur Jacinto, Rachid Eduardo Noleto da Nóbrega Oliveira, José Elias Miziara, Pedro De Marchi, Miguel A Molina-Vila, Letícia Ferro Leal, Rui Manuel Re |
| Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA. Annals of oncology : official journal of the European Society for Medical Oncology 2024 6 . E Felip, B C Cho, V Gutiérrez, A Alip, B Besse, S Lu, A I Spira, N Girard, R Califano, S M Gadgeel, J C-H Yang, S Yamamoto, K Azuma, Y J Kim, K-H Lee, P Danchaivijitr, C G Ferreira, Y Cheng, M A N Sendur, G-C Chang, C-C Wang, K Prabhash, Y Shinno, D Stroyakovskiy, L Paz-Ares, J R Rodriguez-Cid, C Martin, M R G Campelo, H Hayashi, D Nguyen, P Tomasini, M Gottfried, C Dooms, A Passaro, M Schuler, A C Z Gelatti, S Owen, K Perdrizet, S-H I Ou, J C Curtin, J Zhang, M Gormley, T Sun, A Panchal, M Ennis, E Fennema, M Daksh, S Sethi, J M Bauml, S-H L |
| Resectable Non-Small Cell Lung Cancer Heterogeneity and Recurrence Assessed by Tissue Next-Generation Sequencing Genotyping and Circulating Tumor Cell EZH2 Characterization. Archivos de bronconeumologia 2024 10 . Abel Garcia-Diaz, María José Moyano-Rodríguez, María Del Carmen Garrido-Navas, Diego de Miguel-Perez, Jose Expósito-Hernández, Bernardino Alcázar-Navarrete, Francisco Ortuño, David Landeira, Pedro J Romero, Adrian Garcia-Moreno, Jose A Lorente, Javier Lopez-Hidalgo, Clara Bayarri-Lara, Maria Jose Serra |
| Identification of immune-related gene signature model for predicting lung cancer survival and response to immunotherapy. Oncology 2024 10 1-25. Wenrong Lin, XiaoJun Cai, YiJin Lin, Weikun Su, Guibin Weng, Lin Chen, Jianming Ding, Yibin C |
| Afatinib plus bevacizumab combination after osimertinib resistance in advanced EGFR-mutant non-small cell lung cancer: Phase II ABCD-study. Lung cancer (Amsterdam, Netherlands) 2024 10 197 107988. Akito Hata, Nobuyuki Katakami, Naoto Takase, Kayoko Kibata, Yuta Yamanaka, Motohiro Tamiya, Masahide Mori, Takashi Kijima, Satoshi Morita, Kazuko Sakai, Kazuto Nish |
- Page last reviewed:Feb 1, 2024
- Content source: